liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
High ANKZF1 expression is associated with poor overall survival and recurrence-free survival in colon cancer
Sichuan Univ, Peoples R China.
Sichuan Univ, Peoples R China.
Sichuan Univ, Peoples R China.
Linköpings universitet, Institutionen för klinisk och experimentell medicin, Avdelningen för Kirurgi, Ortopedi och Onkologi. Linköpings universitet, Medicinska fakulteten. Sichuan Univ, Peoples R China; Sichuan Univ, Peoples R China.
Vise andre og tillknytning
2019 (engelsk)Inngår i: Future Oncology, ISSN 1479-6694, E-ISSN 1744-8301, Vol. 15, nr 18, s. 2093-2106Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Aim: To investigate the association and prognostic value of ANKZF1 gene for survival in colorectal cancer, the mechanism of ANKZF1 level alteration and correlated signaling pathways ANKZF1 is involved. Patients amp; methods: The Cancer Genome Atlas COREAD dataset was analyzed by bioinformatical investigation. Results: High ANKZF1 expression is associated with poor overall survival (hazard ratio [HR]: 2.094; 95% CI: 1.188-3.689; p=0.011) and recurrence-free survival (HR: 1.762; 95% CI: 1.021-3.042; p=0.042) in colon cancer. Bioinformatical analysis showed ANKZF1 was upregulated by amplification and exon expression. ANKZF1 was associated with angiogenesis and cancer signaling pathways. Conclusion: High ANKZF1 is an independent factor of poor survival (overall survival and recurrence-free survival) in colon cancer by taking part in angiogenesis and some cancer signaling pathways.

sted, utgiver, år, opplag, sider
FUTURE MEDICINE LTD , 2019. Vol. 15, nr 18, s. 2093-2106
Emneord [en]
ANKZF1; colon cancer; OS; overall survival; recurrence-free survival; RFS; WGCNA
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-160630DOI: 10.2217/fon-2018-0920ISI: 000485097700004PubMedID: 31257922OAI: oai:DiVA.org:liu-160630DiVA, id: diva2:1360198
Merknad

Funding Agencies|Natural Science Foundation of ChinaNational Natural Science Foundation of China [81402446]; Research Foundation of Health and Family Planning Commission of Sichuan Province [150136]

Tilgjengelig fra: 2019-10-11 Laget: 2019-10-11 Sist oppdatert: 2019-10-11

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMed

Søk i DiVA

Av forfatter/redaktør
Fan, Chuanwen
Av organisasjonen
I samme tidsskrift
Future Oncology

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 48 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf